India Pharma Looks Beyond US Amid Trade Risks, Says GlobalData
As uncertainty grows over its long-term access to the US market, India’s pharma industry looks beyond US as trade uncertainty grows.
India Pharma Exports | 12/10/2026 | By News Bureau | 190
Pharmexcil’s iPHEX 2026 records USD 4.5-5 billion in potential business discussions, attracting buyers from 128 countries, with the next edition set for 2027.
India Pharma Exports | 11/09/2026 | By News Bureau | 254
Trump's Proposed Tariffs on Generic Drug Imports Raise Concerns for India's Pharmaceutical Industry
The US plans to impose a 100 percent tariff on imported generic medicines from August 2028, increasing to 200 percent a year later, prompting Indian drugmakers to reassess export strategies and manufacturing plans.
India Pharma Exports | 23/07/2026 | By News Bureau
India-UK FTA to Boost Pharma Exports Beyond USD 981 Million in FY2026-27: Pharmexcil
India-UK FTA is expected to boost India's pharmaceutical exports to the UK beyond USD 981 million in FY2026-27, building on strong export growth, according to Pharmexcil.
India Pharma Exports | 16/07/2026 | By News Bureau | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy